CAS 1203490-23-6

Formula: C21H27ClO5

InChI: InChI=1S/C21H27ClO5/c1-21(2,15-3-7-19(8-4-15)26-13-17(24)11-22)16-5-9-20(10-6-16)27-14-18(25)12-23/h3-10,17-18,23-25H,11-14H2,1-2H3/t17-,18-/m1/s1

InChI key: HDTYUHNZRYZEEB-QZTJIDSGSA-N

SMILES: CC(C)(C1=CC=C(C=C1)OC[C@@H](CO)O)C2=CC=C(C=C2)OC[C@@H](CCl)O

(R)-3-(4-(2-(4-((S)-3-Chloro-2-hydroxypropoxy)phenyl)propan-2-yl)phenoxy)propane-1,2-diol

CAS: 1203490-23-6

Formula: C₂₁H₂₇ClO₅

Purity: 97%

Color and Shape: Solid

Molecular weight: 394.8891

Ref: IN-DA01KL3L

Ralaniten

CAS: 1203490-23-6

Ralaniten

Formula: C₂₁H₂₇ClO₅

Purity: ≥98%

Molecular weight: 394.89

Ref: 54-BUP12275

(R)-3-[4-[1-[4-[(S)-3-Chloro-2-hydroxypropoxy] phenyl]-1-methylethyl]phenoxy]-1,2-propanediol

CAS: 1203490-23-6

(R)-3-[4-[1-[4-[(S)-3-Chloro-2-hydroxypropoxy]phenyl]-1-methylethyl]phenoxy]-1,2-propanediol is a retinoid that is used in cancer chemotherapy. It binds to the retinoic acid receptor and may be useful as an anticancer agent. The chemical structure of this drug is similar to all-trans retinoic acid, but it has low potency and does not induce skin irritation. (R)-3-[4-[1-[4-[(S)-3-Chloro-2-hydroxypropoxy]phenyl]-1-methylethyl]phenoxy]-1,2-propanediol has shown promise for treating prostate cancer cells resistant to antiandrogen therapy with a high potency and low toxicity profile. This drug also has pharmacokinetic properties that allow for effective delivery across the blood brain barrier and

Formula: C₂₁H₂₇ClO₅

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 394.9 g/mol

Ref: 3D-DYB49023

Ralaniten

CAS: 1203490-23-6

(R)-3-(4-(2-(4-((S)-3-Chloro-2-hydroxypropoxy)phenyl)propan-2-yl)phenoxy)propane-1,2-diol

Formula: C₂₁H₂₇ClO₅

Purity: 97%

Molecular weight: 394.89

Ref: IN-DG01095470

Ralaniten

CAS: 1203490-23-6

Ralaniten (EPI-002), a potent AR-NTD antagonist, inhibits AR with IC50 of 7.4 μM, for CRPC study.

Formula: C₂₁H₂₇ClO₅

Purity: 99.96%

Color and Shape: Solid

Molecular weight: 394.89

Ref: TM-T28502